Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Self-precipitating pharmaceutical formulations for the modified release of an active principle

Self-precipitating pharmaceutical formulations for the modified release of an active principle

US Patent 8236353 · Granted Aug 7, 2012

Estimated economic value: $1,643,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions in the form of an injectable aqueous solution comprising amylin, an2025
Injectable pH 7 solution comprising at least one basal insulin having a pI from 2024
Injectable solution at pH 7 comprising at least one basal insulin wherein the pI2023
Compositions in the form of an injectable aqueous solution comprising human gluc2021
Compositions in the form of an injectable aqueous solution comprising amylin, an2021
Compositions in the form of an injectable aqueous solution comprising amylin, an2021
Compositions in the form of an injectable aqueous solution including at least hu2021
Compositions in the form of an injectable aqueous solution comprising human gluc2021
Compositions in the form of an injectable aqueous solution including at least hu2020
Oral medicinal product with modified release of at least one active principle in2018
Composition comprising an active agent with low aqueous solubility2018
Composition comprising an active agent with low aqueous solubility2018